Skip to main content
SpringerLink
Log in

Efficacy Assessment in Paediatric Studies

  • Chapter
  • First Online:
Pediatric Clinical Pharmacology

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 205))

Abstract

Even though the regulatory authorities to some extent accept the extra-polation of efficacy data from adults to paediatric patients, it is often the case that differences in the disease process and the developmental stage of the children prevent the extrapolation of efficacy in these populations. Where efficacy studies are needed, the development, validation, and employment of different endpoints for specific age and developmental subgroups become necessary. Children are in continuous development and any measure to assess the efficacy of an intervention should take carefully into account how this development affects the endpoints, including the performance capacity of the child and differences in the condition and symptoms presented. Clinical endpoints that are used in the adult trials to evaluate treatment effect may not be suitable in paediatric studies. The development of surrogate endpoints for benefit and risk assessment in children is necessary. Collaboration between the academic researchers, pharmaceutical industry, and regulatory authorities is needed to meet the challenges in proper validation of biomarkers and surrogate endpoints in paediatric trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abu-Afereh I, Russel G (1994) Prevalence of headache and migraine in school children. BMJ 309:765–769

    Google Scholar 

  • Ahonen K, Hämäläinen ML, Rantala H, Hoppu K (2004) Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 62:883–887

    PubMed  CAS  Google Scholar 

  • Ahonen K, Hämäläinen ML, Eerola M, Hoppu K (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67:1135–1140

    Article  PubMed  CAS  Google Scholar 

  • Anand KJ, Hall RW, Desai N, Shepard B, Bergqvist LL, Young TE, Boyle EM, Carbajal R, Bhutani VK, Moore MB, Kronsberg SS (2004) NEOPAIN Trial Investigators Group. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 363:1673–1682

    Article  PubMed  CAS  Google Scholar 

  • Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Glaxo Wellcome International Septic Shock Study Group (2004) Administration of the nitric oxide synthase inhibitor NG-methyl L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no 144-002). Crit Care Med 32:1–12

    Article  PubMed  CAS  Google Scholar 

  • Benjamin DK Jr, Smith PB, Jadhav P, Gobburu JV, Murphy MD, Hasselblad V, Baker-Smith C, Califf RM, Li JS (2008) Paediatric antihypertensive trial failures: analysis of endpoints and dose range. Hypertension 51:834–840

    Article  PubMed  CAS  Google Scholar 

  • Best Pharmaceuticals for children Act (2002) Public Law No 107–109

    Google Scholar 

  • Beydon N, on behalf of the American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing et al (2007) An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304–1345

    Article  PubMed  Google Scholar 

  • Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95

    Article  Google Scholar 

  • Brierley J et al (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688

    Article  PubMed  Google Scholar 

  • Bringuier S, Dadure C, Raux O, Dubois A, Picot M-C, Capdevila X (2009) The perioperative validity of the visual analog anxiety scale in children: a discriminant and useful instrument in routine clinical practice to optimize postoperative pain management. Anesth Analg 109:737–744

    Article  PubMed  Google Scholar 

  • Buysse CM, Raat H, Hazelzet JA, Hop WC, Maliepaard M, Joosten KFM (2008) Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med 36:596–602

    Article  PubMed  Google Scholar 

  • Carcillo JA, Fields AI, Task force committee members (2002) Clinical practice parameters for hemodynamic support of paediatric an neonatal patients in septic shock. Crit Care Med 30:1365–1378

    Article  PubMed  Google Scholar 

  • Champion GD, Goodenough B, von Baeyer CL, Thomas W (1998) Measurement of pain by self-report. In: Finley GA, McGrath PJ (eds) Measurement of pain in infants and children. IASP, Seattle, WA, pp 123–160

    Google Scholar 

  • Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A, for the Pediatric Rheumatology International Trials Organisation (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658–666

    Article  PubMed  Google Scholar 

  • CPMP/EWP/4151/00 (2009) Rev. 1. Guideline on the requirements for clinical documentation for Orally Inhaled Products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and for use in the treatment of Asthma in children and adolescents

    Google Scholar 

  • CPMP/EWP/422/04 (2007) Guideline on clinical investigation of medicinal products for the treatment of juvenile idiopathic arthritis

    Google Scholar 

  • Crawfordt MJ, Lehman L, Slater S, Kabbouche MA, LeCates SL, Segers A, Manning P, Powers SW, Hershey AD (2009) Menstrual migraine in adolescents. Headache 49:341–347

    Article  Google Scholar 

  • Crenesse D, Berlioz M, Bourrier T, Albertini M (2001) Spirometry in children aged 3 to 5 years: reliability of forced expiratory maneuvers. Pediatr Pulmonol 32:56–61

    Article  PubMed  CAS  Google Scholar 

  • Curley MA, Zimmerman JL (2005) Alternative outcome measures for pediatric clinical sepsis trials. Pediatr Crit Care Med 6(Suppl):S150–S156

    Article  PubMed  Google Scholar 

  • Dancey JE, Dobbin KK, Groshen S, Milburn Jessup J, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR, On behalf of the Biomarkers Task Force of the NCI Investigational Drug Steering Committee (2010) Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. Clin Cancer Res 16:1745–1755

    Article  PubMed  CAS  Google Scholar 

  • Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M (2007) Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc 4:418–430

    Article  PubMed  Google Scholar 

  • Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, Mogayzel PJ, Johnson RC, Wilcox SL, Castile RG (2010) Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 182(11):1387–1397

    Article  PubMed  Google Scholar 

  • de Oliveira CF, de Oliveira DSF, Gottschald AFC, Moura JDG, Costa GA, Ventura AC, Fernandes JC, Vaz FAC, Carcillo JA, Rivers EP, Troster EJ (2008) ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 34:1065–1075

    Article  PubMed  Google Scholar 

  • Debillon T, Zupan V, Ravault N, Magny J-F, Dehan M (2001) Development and initial validation of the EDIN scale, a new tool for assessing prolonged pain in preterm infants. Arch Dis Child Fetal Neonatal Ed 85:F36–F41

    Article  PubMed  CAS  Google Scholar 

  • Della Pasqua O, Zimmerhackl L-B, Rose K (2007) Study protocol design for paediatric patients of different ages. In: Rose K, van den Acker JN (eds) Guide to paediatric clinical research. Basel, Karger, pp 87–107

    Google Scholar 

  • Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McGormick GC, Mc Dermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollet J, Wernicke J, Witter J (2005) Core outcome measures for chronic pain trials: IMMPACT recommendations. Pain 113:9–19

    Article  PubMed  Google Scholar 

  • Eccleston C, Jordan A, McCracken LM, Sleed M, Connell H, Clinch J (2005) The Bath Adolescent Pain Questionnaire (BAPQ): development and preliminary psychometric evaluation of an instrument to assess the impact of chronic pain on adolescents. Pain 118:263–270

    Article  PubMed  Google Scholar 

  • Echt BS, Liebson PR, Mitchell LB (1991) Mortality and morbidity in patients receiving ecainide, flecainide or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324:781–788

    Article  PubMed  CAS  Google Scholar 

  • EMA/CHMP/EWP/213972/2010 (2010) Paediatric addendum to CHMP guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension

    Google Scholar 

  • EMEA/522496/2006 (2006a) Report on the EMEA/CHMP biomarkers workshop

    Google Scholar 

  • EMEA/536810/08 (2008a) Guideline on the Investigation of medicinal products in the term and preterm neonate

    Google Scholar 

  • EMEA/CHMP/EWP/139391/2004 (2004) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products

    Google Scholar 

  • EMEA/CHMP/EWP/4713/03 (2006b) Guideline on clinical investigation of medicinal products for the treatment of sepsis

    Google Scholar 

  • EMEA/CHMP/EWP/517497/2007 (2008b) Guideline on clinical evaluation of medicinal products used in weight control (cpmp/ewp/281/96 rev. 1) Addendum on weight control in children

    Google Scholar 

  • EMEA/CHMP/EWP/545456/2008 (2008c) Concept paper on the need for the development of a paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension

    Google Scholar 

  • EMEA/CHMP/EWP/644261/2008 (2009c) Concept paper on the need for the development of a paediatric addendum to the CHMP guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension

    Google Scholar 

  • EMEA/CHMP/EWP/9147/2008 (2009b) Guideline on the clinical development of medicinal products for the treatment of cystic fibrosis

    Google Scholar 

  • EMEA/CHMP/ICH/380636/2009 (2009a) Note for guidance on genomic biomarkers related to drug response: context, structure and format of qualification submissions

    Google Scholar 

  • EMEA/CPMP/EWP/612/00 (2002) Note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain

    Google Scholar 

  • EMEA/CPMP/EWP/788/01 (2007) Rev. 1. Guideline on clinical investigation of medicinal products for the treatment of migraine

    Google Scholar 

  • Evers S, Marziniak M, Frese A, Gralow I (2008) Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies. Cephalgia 29:436–444

    Article  Google Scholar 

  • Fleming TR, DeMets DL (1996) Surrogate endpoints in clinical trials: are we being misled? Ann Intern Med 125:605–613

    PubMed  CAS  Google Scholar 

  • Food and Drug Administration (1998) US Departmentof Health and Human Services. Guidance for industry; E9 statistical principles for clinical trials. Office of Training and Communications, Rockville, MD

    Google Scholar 

  • Food and Drug Administration (2003) Code of Federal Regulations 601.40

    Google Scholar 

  • Food and Drug Administration (2009a) Code of Federal Regulations 21 314.50

    Google Scholar 

  • Food and Drug Administration (2009b) Accelerated approval of new drugs for serious or life-threatening illnesses. Code of Federal Regulations, Title 21, Volume 5, revised

    Google Scholar 

  • Food and Drug Administration (2009c) Guidance for industry. Patient-reported outcome measures: use in medicinal product development to support labeling claims

    Google Scholar 

  • Fradet C, McGarth PJ, Kay J, Adams S (1990) A prospective survey of reactions to blood test by children and adolescents. Pain 40:53–60

    Article  PubMed  CAS  Google Scholar 

  • Goldstein B, Giror B, Randolph A, and the Members of the International Consensus Conference of Pediatric Sepsis (2005) International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8

    Article  PubMed  Google Scholar 

  • Grunau RE, Oberlander T, Holsti L, Whitfield MF (1998) Bedside application of the Neonatal Facial Coding System in pain assessment of premature neonates. Pain 76:277–286

    Article  PubMed  CAS  Google Scholar 

  • Hain RGW (1997) Pain scales in children: review. Palliat Med 11:341–350

    Article  PubMed  CAS  Google Scholar 

  • Hämäläinen ML, Hoppu K, Santavuori P (1997) Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology 48:1100–1103

    PubMed  Google Scholar 

  • Haworth SG, Beghetti M (2010) Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension. Curr Opin Pulm Med 16(Suppl 1):S35–S41

    Article  PubMed  Google Scholar 

  • International Conference for Harmonisation (1997) General considerations for Clinical Trials E 8

    Google Scholar 

  • International Conference for Harmonisation (2001) Clinical investigation of medicinal products in the paediatric population E 11. CPMP/ICH/2711/99

    Google Scholar 

  • International Headache Society Headache Classification Subcommittee (2004) International classification of headache disorders, 2nd edition. Cephalgia 24(Suppl 1):9–160

    Google Scholar 

  • Inwald DP, Tasker RC, Peters MJ, on behalf of the Paediatric Intensive Care Society Study Group (PIGS-SG) (2009) Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch Dis Child 94:348–353

    Article  PubMed  CAS  Google Scholar 

  • Jacobson S (2007) Common medical pains. Paediatr Child Health 12:105–109

    PubMed  Google Scholar 

  • Lesko JJ, Atkinson AJ Jr (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41:347–366

    Article  PubMed  CAS  Google Scholar 

  • Lewis DW, Winner P, Wasiewski W (2005) The placebo responder rate in children and adolescents. Headache 45:232–239

    Article  PubMed  Google Scholar 

  • Lewis DW, Paul Winner P, Hershey AD, Warren W, Wasiewski WW, on behalf of the Adolescent Migraine Steering Committee (2007) Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120:390–396

    Article  PubMed  Google Scholar 

  • Li AM et al (2005) The six-minute walk test in healthy children: reliability and validity. Eur Respir J 25:1057–1060

    Article  PubMed  CAS  Google Scholar 

  • Li JS, Benjamin DK Jr, Severin T, Portman RJ (2010) Paediatric anti-hypertensive clinical trials and various factors influencing trial success or failure. In: Rose K, van den Anker JN (eds) Guide to paediatric drug development and clinical research. Karger, Basel, pp 196–205

    Chapter  Google Scholar 

  • Loizzo A, Stefano Loizzo S, Capasso A (2009) Neurobiology of pain in children: an overview. Open Biochem J 3:18–25

    Article  PubMed  Google Scholar 

  • López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21–30

    Article  PubMed  Google Scholar 

  • Madriago E, Silberbach M (2010) Heart failure in infants and children. Pediatr Rev 31(1):4–11

    Article  PubMed  Google Scholar 

  • McGrath PJ, Walco GA, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley GA, Goldschneider K, Haverkos L, Hertz SH, Ljungman G, Palermo T, Rappaport BA, Rhodes T, Schechter N, Scott J, Sethna N, Svensson OK, Stinson J, von Bayer CL, Walker L, Weisman S, White RE, Zajick A, Zeltzer L (2008) Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 9:771–783

    Article  PubMed  Google Scholar 

  • Merkel SI, Voepel-Lewis T (1997) The FLACC: a behavioural scale for scoring postoperative pain in young children. Pediatr Nurs 23:293–297

    PubMed  CAS  Google Scholar 

  • Merskey H, Bogduk N (eds) (1994). Part III: pain terms, a current list with definitions and notes on usage. In: Classification of chronic pain, 2nd edn. IASP Task Force on Taxonomy. IASP Press, Seattle WA, pp 209–214

    Google Scholar 

  • Molenberghs G, Orman C (2009) Surrogate endpoints: application in pediatric clinical trials. In: Mulberg A, Silber S, vand der Acker JN (eds) Pediatric drug development, concepts and applications. Wiley-Blackwell, Hoboken, NJ, pp 501–511

    Google Scholar 

  • Mortimer MJ, Kay J, Jaron A (1992) Childhood migraine in general practice: clinical features and characteristics. Cephalgia 12:238–253

    Article  CAS  Google Scholar 

  • Nilsson S, Finnström B, Kosinky E (2008) The FLACC behavioural scale for procedural pain assessment in children aged 5–16 years. Pediatr Anesth 18:767–774

    Article  Google Scholar 

  • Odetola FO, Gebremariam A, Freed GL (2007) Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 119:487–494

    Article  PubMed  Google Scholar 

  • Paediatric Research Equity Act (2003) Public Law No 108–155

    Google Scholar 

  • Puntman VO (2009) How-to guide on biomarkers: biomarker definitons, validation and applications with examples from cardiovascular disease. Postgrad Med J 85:538–545

    Article  Google Scholar 

  • Redmond C, Colton T (eds) (2001) Biostatistics in clinical trials, Wiley reference series in biostatistics., p 322, Outcome measure

    Google Scholar 

  • Regulation (EC) (2006) No 1901/2006 On medicinal products for paediatric use

    Google Scholar 

  • Regulation (EC) No 726/2004 (2004) On conditional approval of medicinal products

    Google Scholar 

  • Rosenfeld M (2007) An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thorac Soc 4:299–301

    Article  PubMed  Google Scholar 

  • Ross RD, Bollinger RO, Pinsky WW (1992) Grading the severity of congestive heart failure in infants. Pediatr Cardiol 13(2):72–75

    Article  PubMed  CAS  Google Scholar 

  • Rothman M, Kleinman L (2009) Patient-reported outcomes in paediatric drug development. In: Mulberg A, Silber S, der Acker JN (eds) Pediatric drug development, concepts and applications. Wiley-Blackwell, Hoboken, NJ, pp 513–524

    Google Scholar 

  • Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46:101–109

    Article  PubMed  Google Scholar 

  • Ruperto N, for the Pediatric Rheumatology International trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCGS) et al (2006) The pediatric rheumatology international trials organization/American college of rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum (Arthritis Care Res) 55(3):355–363

    Article  Google Scholar 

  • Shaddy RE, for the Pediatric Carvedilol Study Group et al (2007) Carvedilol for children and adolescents with heart failure. JAMA 298(10):1171–1179

    Article  PubMed  Google Scholar 

  • Sinha I, Jones L, Smyth RL, Williamson PR (2008) A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 5:e96

    Article  PubMed  Google Scholar 

  • Slater R, Cantarella A, Franck L, Meek J, Fitzgerald M (2008) How well do clinical pain assessment tools reflect pain in infants? PLoS Med 6:e129

    Article  Google Scholar 

  • Stanford EA, Chambers CT, Graig KD (2006) The role of developmental factors in predicting young children’s use of self-report scale for pain. Pain 120:16–23

    Article  PubMed  Google Scholar 

  • Stevens B, Johnston C, Petryshen P, Taddio A (1996) Premature infant pain profile: development and initial validation. Clin J Pain 12:13–22

    Article  PubMed  CAS  Google Scholar 

  • Stinson JN, Kabanagh T, Yamada J, Gill N, Stevens B (2006) Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain 125:143–157

    Article  PubMed  Google Scholar 

  • The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509–516

    Article  Google Scholar 

  • Tugwell P, Boers M (1993) OMERACT conference on outcome measures in RA clinical trials: introduction. J Rheumatol 20:528–530

    PubMed  CAS  Google Scholar 

  • University of Liverpool (2010) Core Outcome Measures in Effectiveness Trials (COMET). http://www.liv.ac.uk/nwhtmr/comet/comet.htm

  • van Dijk M, de Boer JB, Koot HM, Tibboel D, Passchier J, Duivenvoorden HJ (2000) The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3 year-old infants. Pain 84:367–377

    Article  PubMed  Google Scholar 

  • Varni JW, Seid M, Rode CA (1999) The PEdsQL: measurement model for the Pediatric Quality of Life Inventory. Med Care 37:126–139

    Article  PubMed  CAS  Google Scholar 

  • Varni JW, Seid M, Kurtin PS (2001) PedQL 4.0: reliability and validity of the Pediatric Quality of life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800–812

    Article  PubMed  CAS  Google Scholar 

  • Vincent JL (2004) Endpoints in sepsis trials. More than just 28 day mortality? Crit Care Med 32(Suppl):S209–S213

    Article  PubMed  Google Scholar 

  • von Baeyer CL, Spagrud LJ (2007) Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain 127:140–150

    Article  Google Scholar 

  • von Baeyer CL, Spagrud LJ, McCormick JC, Choo E, Neville K, Connelly MA (2009) Three new datasets supporting the use of the Numerical Rating Scale (NRS-11) for children’s self-reports on pain intensity. Pain 143:223–227

    Article  Google Scholar 

  • Walco GA, Conte PM, Labay LE, Engel R, Zeltzer LK (2005) Procedural distress in children with cancer: self-report, behavioral observations, and physiological parameters. Clin J Pain 21:484–490

    Article  PubMed  Google Scholar 

  • Walco G, Dworkin RH, Krane EJ, LeBel AA, Treede R-D (2010) Neuropathic pain in children: special considerations. Mayo Clin Proc 85(Suppl):S33–S41

    Article  PubMed  Google Scholar 

  • Walker SM (2008) Pain in children: recent advances and ongoing challenges. Br J Anaesth 101:101–110

    Article  PubMed  CAS  Google Scholar 

  • Watson RS, Carcillo JA (2005) Scope and epidemiology in pediatric sepsis. Pediatr Crit Care Med 6(Suppl):S3–S5

    Article  PubMed  Google Scholar 

  • Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Glaxo Wellcome International Septic Shock Study Group (2004) Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl l-arginine hydrochloride (546C88) in patients with septic schock: results of a randomized, double-blind, placebo-controlled multicenter study (study no 144–002). Crit Care Med 32:13–20

    Article  PubMed  CAS  Google Scholar 

  • Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V (2007) Eletriptan for acute treatment of migraine in adolescents: results of a double-blind placebo-controlled trial. Headache 47:511–518

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Norwegian Medicines Agency, Tønsberg Hospital Pharmacy, Sven Oftedalsvei 6, N-0950, Oslo, Norway

    Siri Wang

  2. Health Care and Social Services, City of Hyvinkää, Suutarinkatu 2 C, 05801, Hyvinkää, Finland

    Pirjo Laitinen-Parkkonen

Authors
  1. Siri Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pirjo Laitinen-Parkkonen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siri Wang .

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Univ.Klinikum Marburg, Baldingerstr. 12, Marburg, 35043, Germany

    Hannsjörg W. Seyberth

  2. Karolinska Institutet, Dept. Laboratory Medicine, Karolinska University Hostpital, Stockholm, 141 86, Sweden

    Anders Rane

  3. für Klinische Pharmakologie (IKP), Dr. Margarete Fischer-Bosch Institut, Auerbachstr. 112, Stuttgart, 70376, Germany

    Matthias Schwab

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wang, S., Laitinen-Parkkonen, P. (2011). Efficacy Assessment in Paediatric Studies. In: Seyberth, H., Rane, A., Schwab, M. (eds) Pediatric Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 205. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20195-0_7

Download citation

Publish with us

Policies and ethics

Search

Navigation